Chile Extracorporeal Shock Wave Lithotripsy Market Growth & Trends
The Chile extracorporeal shock wave lithotripsy market size is expected to reach USD 3.45 million by 2028, registering a CAGR of 5.9% over the forecast period, according to a new report by Grand View Research, Inc. Increasing risk factors that cause kidney stones and growing preference of patients for minimally invasive procedures coupled with technological advancements are contributing to the market growth. The rising cases of obesity and lifestyle-related diseases are also predicted to contribute to market growth.
Extracorporeal shock wave lithotripsy (ESWL) is a safe and effective method of delivering shock waves for the treatment of stones and physicians around the world generally utilize this technique as it involves less pain, requires low recovery time & a shorter hospital stay, and is non-invasiveness. The COVID-19 pandemic had a significant effect on the healthcare market. During the first wave of COVID-19, the lockdown and restrictions on gathering had a direct impact on productivity. The production units, on the other hand, began reopening in the third quarter of 2020.
The adoption of ESWL is also affected by the factors, such as limitations associated with ESWL and the presence of alternative treatment options. FONASA, Chile’s government-run health insurance scheme, covers 78% of the country’s population. As a result, Chile’s National Health System (SNSS - Sistema Nacional de Servicios de Salud) is the country’s largest buyer. The market is projected to experience a growth spike as the Piera administration continues to implement its hospital infrastructure plan.
Request a free sample copy or view report summary: Chile Extracorporeal Shock Wave Lithotripsy Market Report
Chile Extracorporeal Shock Wave Lithotripsy Market Report Highlights
- The Electrohydraulic Lithotripters (EHL) segment held the largest revenue share in 2020. EHL is portable, efficient, and relatively inexpensive which drive its demand
- The piezoelectric lithotripters segment is anticipated to witness the largest CAGR over the forecast period
- In terms of revenue share, the kidney stone application segment led the market in 2020 owing to increased cases of the disease and its risk factors
- The pancreatic stone segment is predicted to have substantial growth due to the rising demand for technologically improved minimally invasive equipment
- In terms of end use, the hospital segment dominated the market accounting for the maximum revenue share of the global ESWL market in 2020 owing to the availability of technologically advanced infrastructure and medical equipment in hospitals
Access Press Release@ https://www.grandviewresearch.com/press-release/chile-extracorporeal-shock-wave-lithotripsy-market-analysis
Chile Extracorporeal Shock Wave Lithotripsy Market Segmentation
Grand View Research has segmented the Chile extracorporeal shock wave lithotripsy market based on technology, application, and end-use:
Chile ESWL Technology Outlook (Revenue, USD Million, 2016 - 2028)
- Electromagnetic
- Electrohydraulic
- Piezoelectric
Chile ESWL Application Outlook (Revenue, USD Million, 2016 - 2028)
- Kidney Stone
- Pancreatic Stone
- Salivary Stone
- Other
Chile ESWL End-use Outlook (Revenue, USD Million, 2016 - 2028)
- Hospital
- Clinic
- Other
List of Key Players of Chile Extracorporeal Shock Wave Lithotripsy Market
- Boston Scientific Corp.
- Becton, Dickinson and Company
- Cook Medical
- Siemens Healthcare GmbH
- Lumenis
- Olympus
- Dornier MedTech
- Karl Storz Lithotripsy-America, Inc.
- MTS Medical
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
No comments:
Post a Comment